was aimed at the safety of the drug, and wasn't intended to test its efficacy as a treatment of PD.

As for Cogane's pre-clinical results, well we all know if we were rats or monkeys we would be cured by now.

As for Oxford Biomedica's Prosavin, well it appears to work in the Phase I trial, mind you they all do at Phase I, (Spheramine, Ceregene, etc.).

Its all good news and the results for both are better than the alternatives, (i.e. both halted), but there is such a long way to go !!

Neil.